跳到主要内容
Rallybid

筹划中

Supply of HLA Sequencing Systems

NHS Blood and Transplant已就“Supply of HLA Sequencing Systems”发布此招标,现已不再接受新的投标。

此招标已不再接受新的投标。 类似的进行中招标

用通俗的话说,这项招标是什么?

此公告尚未翻译,以原文语言显示。

同类招标的过往中标记录说明了什么?

  • 同类招标平均每项约有 4.8 份投标(5 项中标记录载有数目)。
  • 半数同类合同的中标金额介于 £7,438,375 至 £23,580,000,中位数为 £14,200,748。

根据过去 36 个月 8 项中标记录:相同工种、相同地区、金额相近。可信程度:低。以上仅反映过往情况,并非预测结果。 中标数据

谁赢得了这项招标,金额是多少?

此招标尚未公布中标结果。

公告全文

原文(English)

Supply of HLA Sequencing Systems

NHS Blood & Transplant (NHSBT) Histocompatibility & Immunogenetics function intends to undertake a Procurement Act 2023 tender exercise for the supply of HLA sequencing systems. Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHSBT, providing testing and support in transplantation, specialised transfusion including the supply of selected blood products, immunogenetics, platelet and granulocyte immunology. Services are supplied through a national network of six laboratories across England. Building on our strengths as a national provider, NHSBT’s strategic aim is for its diagnostic services to become the preferred provider and supplier of choice for these services in the NHS in England. We would like to work with future suppliers to realise this ambition and to perform HLA typing in an efficient, timely and cost-effective manner to meet the demands and expectations of our customers and the patients we serve. Prior to commencing a formal procurement process and to help inform our strategy, NHSBT is seeking to engage with suppliers of commercially available HLA sequencing systems. Our current contract ends in August 2028 and NHSBT would like to improve our knowledge of all current and future systems available in the marketplace. This will aid identification of opportunities and gauge market interest in this field. We require HLA typing systems to cover the following: · Allelic Test Kits SHOULD detect and uniquely identify all alleles of the HLA-A, B, C, DRB1, DRB3/4/5, DQA1, DQB1, DPA1 and DPB1 loci at the level of resolution that additionally defines the third field according to WHO nomenclature by at least resolving all ambiguities resulting from: (1) polymorphisms located within the exons coding for HLA class I and class II proteins and (2) that encompass a null allele wherever the polymorphism is located. · The optimal solution SHOULD define fourth field level resolution. · We are not restricting which sequencing platform the allelic test kits are compatible with, however HLA typing should be completed within 72 hours of the start of the process. NB: Procurement of the above systems may be managed by individual tenders. It is NHSBT's intention to hold pre-procurement engagement meetings the week of 21OCT2026 to 23OCT2026 these will be held remotely, the date to be confirmed. To enable NHSBT to finalise arrangements (e.g. send meeting details and agree time slots) for the supplier engagement meetings, interested organisations are required to send an expression of interest via email to coco.otiotio@nhsbt.nhs.uk by no later than 17:00 hrs (GMT) on 09OCT2026. This should include a list of your potential attendees and a brief overview (or a website link) of the Goods / Services which might be offered. Please include options, if available, to offer a managed service contract. No business whatsoever is guaranteed under any resulting framework agreement or contract, and there is no guarantee that any framework agreement or contract will be put in place in relation to this notice. No compensation etc. will be paid if a tender or resulting framework agreement is withdrawn for any reason. Bidders should take part in this process only on the basis that they fully understand and accept this position. It should be noted that this procurement exercise may allow other Health authorities to utilise any contracts/ framework agreements awarded.

通过邮件接收这些招标

每天一封邮件,列出你所选行业和地区的新招标。无需账户或密码。

我们会先通过邮件向你发送确认链接。在你使用链接之前,不会发送任何其他内容。 隐私声明

快速解答

这项招标什么时候截止?

公告没有注明截止日期。请查看采购方的门户网站。

这份合同价值多少?

采购方估计金额为£13,440,000。

采购方是谁?

采购方是NHS Blood and Transplant。

同类招标通常有多少企业投标?

同类招标平均每项约有 4.8 份投标(5 项中标记录载有数目)。 根据过去 36 个月 8 项中标记录:相同工种、相同地区、金额相近。可信程度:低。以上仅反映过往情况,并非预测结果。

类似的进行中招标